Structure

Physi-Chem Properties

Molecular Weight:  574.39
Volume:  607.46
LogP:  4.38
LogD:  3.762
LogS:  -4.525
# Rotatable Bonds:  5
TPSA:  102.29
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.334
Synthetic Accessibility Score:  5.313
Fsp3:  0.882
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.084
MDCK Permeability:  2.6522793632466346e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.08
30% Bioavailability (F30%):  0.805

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.013
Plasma Protein Binding (PPB):  87.3049087524414%
Volume Distribution (VD):  1.129
Pgp-substrate:  6.749740123748779%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.089
CYP2C19-inhibitor:  0.012
CYP2C19-substrate:  0.769
CYP2C9-inhibitor:  0.079
CYP2C9-substrate:  0.081
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.076
CYP3A4-inhibitor:  0.3
CYP3A4-substrate:  0.425

ADMET: Excretion

Clearance (CL):  2.844
Half-life (T1/2):  0.3

ADMET: Toxicity

hERG Blockers:  0.078
Human Hepatotoxicity (H-HT):  0.461
Drug-inuced Liver Injury (DILI):  0.634
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.053
Maximum Recommended Daily Dose:  0.175
Skin Sensitization:  0.727
Carcinogencity:  0.014
Eye Corrosion:  0.004
Eye Irritation:  0.014
Respiratory Toxicity:  0.953

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470066

Natural Product ID:  NPC470066
Common Name*:   Chisiamol C
IUPAC Name:   [(3R,5R,7R,8R,9R,10S,13S,17R)-7-acetyloxy-17-[(3S,5R,6S)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-4,4,8,10,13-pentamethyl-2,3,5,6,7,9,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Synonyms:   Chisiamol C
Standard InCHIKey:  OTTULKBJOIKGDJ-SSYPYUHNSA-N
Standard InCHI:  InChI=1S/C34H54O7/c1-19(35)40-27-13-15-33(8)25-12-14-32(7)22(21-16-23(37)29(38)31(5,6)39-18-21)10-11-24(32)34(25,9)28(41-20(2)36)17-26(33)30(27,3)4/h11,21-23,25-29,37-38H,10,12-18H2,1-9H3/t21-,22-,23-,25-,26+,27-,28-,29+,32+,33-,34+/m1/s1
SMILES:  CC(=O)O[C@@H]1C[C@H]2C(C)(C)[C@@H](CC[C@@]2([C@@H]2[C@]1(C)C1=CC[C@@H]([C@]1(C)CC2)[C@H]1COC([C@H]([C@@H](C1)O)O)(C)C)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1668620
PubChem CID:   53323605
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[19943621]
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota twigs Xishuangbanna, Yunnan, China 2007-May PMID[21288727]
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[32208696]
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 8700.0 nM PMID[533082]
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 100000.0 nM PMID[533082]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470066 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470067
0.957 High Similarity NPC470068
0.9368 High Similarity NPC470054
0.9271 High Similarity NPC470053
0.9082 High Similarity NPC470062
0.9082 High Similarity NPC470057
0.9082 High Similarity NPC470059
0.9082 High Similarity NPC470061
0.9082 High Similarity NPC470043
0.9082 High Similarity NPC470060
0.9082 High Similarity NPC470058
0.9082 High Similarity NPC470064
0.8824 High Similarity NPC250956
0.8776 High Similarity NPC155974
0.8763 High Similarity NPC102426
0.8763 High Similarity NPC300179
0.875 High Similarity NPC471903
0.8723 High Similarity NPC210268
0.8673 High Similarity NPC208358
0.866 High Similarity NPC475032
0.866 High Similarity NPC475033
0.8654 High Similarity NPC234042
0.8654 High Similarity NPC152117
0.8614 High Similarity NPC470056
0.8614 High Similarity NPC470055
0.8614 High Similarity NPC473199
0.8614 High Similarity NPC472655
0.86 High Similarity NPC474124
0.8586 High Similarity NPC475617
0.8586 High Similarity NPC289670
0.8571 High Similarity NPC477876
0.8571 High Similarity NPC477875
0.8557 High Similarity NPC253115
0.8557 High Similarity NPC304899
0.8544 High Similarity NPC218853
0.8529 High Similarity NPC469318
0.8529 High Similarity NPC473173
0.8526 High Similarity NPC219516
0.8515 High Similarity NPC85593
0.8515 High Similarity NPC31430
0.8515 High Similarity NPC473543
0.85 High Similarity NPC475344
0.85 High Similarity NPC476471
0.8485 Intermediate Similarity NPC473510
0.8454 Intermediate Similarity NPC30677
0.8454 Intermediate Similarity NPC469329
0.8454 Intermediate Similarity NPC180557
0.8454 Intermediate Similarity NPC473415
0.8454 Intermediate Similarity NPC37787
0.8447 Intermediate Similarity NPC472988
0.8447 Intermediate Similarity NPC38217
0.8416 Intermediate Similarity NPC473523
0.84 Intermediate Similarity NPC476132
0.8384 Intermediate Similarity NPC119036
0.8365 Intermediate Similarity NPC51925
0.8365 Intermediate Similarity NPC43976
0.8365 Intermediate Similarity NPC125361
0.8365 Intermediate Similarity NPC154085
0.8365 Intermediate Similarity NPC296761
0.835 Intermediate Similarity NPC234160
0.8317 Intermediate Similarity NPC136816
0.8302 Intermediate Similarity NPC470063
0.83 Intermediate Similarity NPC474571
0.83 Intermediate Similarity NPC167974
0.83 Intermediate Similarity NPC476195
0.83 Intermediate Similarity NPC230546
0.83 Intermediate Similarity NPC254567
0.8298 Intermediate Similarity NPC189777
0.8283 Intermediate Similarity NPC210337
0.8269 Intermediate Similarity NPC472218
0.8269 Intermediate Similarity NPC472217
0.8269 Intermediate Similarity NPC472219
0.8265 Intermediate Similarity NPC279974
0.8265 Intermediate Similarity NPC86893
0.8265 Intermediate Similarity NPC292178
0.8235 Intermediate Similarity NPC475334
0.8235 Intermediate Similarity NPC473694
0.8235 Intermediate Similarity NPC475623
0.8229 Intermediate Similarity NPC473269
0.8229 Intermediate Similarity NPC10274
0.8218 Intermediate Similarity NPC309425
0.8218 Intermediate Similarity NPC235920
0.8218 Intermediate Similarity NPC160734
0.8218 Intermediate Similarity NPC129372
0.8218 Intermediate Similarity NPC4831
0.8218 Intermediate Similarity NPC96784
0.8218 Intermediate Similarity NPC472023
0.8218 Intermediate Similarity NPC88000
0.8218 Intermediate Similarity NPC47566
0.8208 Intermediate Similarity NPC114188
0.8208 Intermediate Similarity NPC470076
0.8208 Intermediate Similarity NPC65167
0.82 Intermediate Similarity NPC234287
0.82 Intermediate Similarity NPC280825
0.82 Intermediate Similarity NPC247233
0.82 Intermediate Similarity NPC476895
0.8191 Intermediate Similarity NPC474970
0.819 Intermediate Similarity NPC284828
0.819 Intermediate Similarity NPC173905
0.819 Intermediate Similarity NPC472216
0.819 Intermediate Similarity NPC5475
0.8182 Intermediate Similarity NPC475304
0.8182 Intermediate Similarity NPC88009
0.8182 Intermediate Similarity NPC475178
0.8182 Intermediate Similarity NPC471777
0.8182 Intermediate Similarity NPC54248
0.8182 Intermediate Similarity NPC276103
0.8172 Intermediate Similarity NPC299963
0.8163 Intermediate Similarity NPC474922
0.8163 Intermediate Similarity NPC211238
0.8155 Intermediate Similarity NPC288502
0.8155 Intermediate Similarity NPC181104
0.8155 Intermediate Similarity NPC475331
0.8155 Intermediate Similarity NPC121518
0.8155 Intermediate Similarity NPC475335
0.8155 Intermediate Similarity NPC475585
0.8155 Intermediate Similarity NPC474550
0.8155 Intermediate Similarity NPC201144
0.8155 Intermediate Similarity NPC80809
0.8155 Intermediate Similarity NPC103298
0.8155 Intermediate Similarity NPC473577
0.8144 Intermediate Similarity NPC473166
0.8137 Intermediate Similarity NPC154452
0.8119 Intermediate Similarity NPC7341
0.8119 Intermediate Similarity NPC38855
0.8119 Intermediate Similarity NPC473200
0.8113 Intermediate Similarity NPC475563
0.8113 Intermediate Similarity NPC470065
0.8113 Intermediate Similarity NPC475134
0.8113 Intermediate Similarity NPC101450
0.8113 Intermediate Similarity NPC5284
0.81 Intermediate Similarity NPC272451
0.81 Intermediate Similarity NPC476893
0.81 Intermediate Similarity NPC254121
0.8095 Intermediate Similarity NPC258323
0.8085 Intermediate Similarity NPC290731
0.8077 Intermediate Similarity NPC220217
0.8077 Intermediate Similarity NPC470587
0.8077 Intermediate Similarity NPC119855
0.8077 Intermediate Similarity NPC472898
0.8077 Intermediate Similarity NPC477877
0.8077 Intermediate Similarity NPC60315
0.8077 Intermediate Similarity NPC472900
0.8077 Intermediate Similarity NPC475290
0.8077 Intermediate Similarity NPC472899
0.8061 Intermediate Similarity NPC473678
0.8058 Intermediate Similarity NPC31907
0.8058 Intermediate Similarity NPC114874
0.8058 Intermediate Similarity NPC155010
0.8058 Intermediate Similarity NPC472252
0.8058 Intermediate Similarity NPC222153
0.8058 Intermediate Similarity NPC120123
0.8058 Intermediate Similarity NPC473020
0.8058 Intermediate Similarity NPC218513
0.8058 Intermediate Similarity NPC211879
0.8058 Intermediate Similarity NPC157659
0.8058 Intermediate Similarity NPC189852
0.8058 Intermediate Similarity NPC472821
0.8058 Intermediate Similarity NPC131479
0.8058 Intermediate Similarity NPC8039
0.8058 Intermediate Similarity NPC473198
0.8058 Intermediate Similarity NPC286969
0.8058 Intermediate Similarity NPC245280
0.8058 Intermediate Similarity NPC55954
0.8058 Intermediate Similarity NPC16520
0.8058 Intermediate Similarity NPC213190
0.8056 Intermediate Similarity NPC255017
0.8056 Intermediate Similarity NPC144068
0.8039 Intermediate Similarity NPC11974
0.8039 Intermediate Similarity NPC21064
0.8039 Intermediate Similarity NPC476896
0.8039 Intermediate Similarity NPC121072
0.8037 Intermediate Similarity NPC475480
0.8037 Intermediate Similarity NPC475668
0.8037 Intermediate Similarity NPC473921
0.802 Intermediate Similarity NPC477928
0.802 Intermediate Similarity NPC218107
0.802 Intermediate Similarity NPC5358
0.802 Intermediate Similarity NPC216260
0.8019 Intermediate Similarity NPC41405
0.8 Intermediate Similarity NPC473586
0.8 Intermediate Similarity NPC155531
0.8 Intermediate Similarity NPC215968
0.8 Intermediate Similarity NPC306797
0.8 Intermediate Similarity NPC214315
0.8 Intermediate Similarity NPC129569
0.8 Intermediate Similarity NPC227583
0.8 Intermediate Similarity NPC292718
0.8 Intermediate Similarity NPC169270
0.8 Intermediate Similarity NPC98457
0.8 Intermediate Similarity NPC111834
0.8 Intermediate Similarity NPC12103
0.8 Intermediate Similarity NPC59530
0.7981 Intermediate Similarity NPC471293
0.7981 Intermediate Similarity NPC187400
0.7981 Intermediate Similarity NPC470885
0.7981 Intermediate Similarity NPC273879
0.7981 Intermediate Similarity NPC173583
0.7981 Intermediate Similarity NPC221562
0.7981 Intermediate Similarity NPC165033

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470066 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7742 Intermediate Similarity NPD7525 Registered
0.7719 Intermediate Similarity NPD8033 Approved
0.767 Intermediate Similarity NPD7638 Approved
0.7632 Intermediate Similarity NPD8294 Approved
0.7632 Intermediate Similarity NPD8377 Approved
0.7611 Intermediate Similarity NPD7328 Approved
0.7611 Intermediate Similarity NPD7327 Approved
0.7596 Intermediate Similarity NPD7639 Approved
0.7596 Intermediate Similarity NPD7640 Approved
0.7565 Intermediate Similarity NPD8380 Approved
0.7565 Intermediate Similarity NPD8335 Approved
0.7565 Intermediate Similarity NPD8378 Approved
0.7565 Intermediate Similarity NPD8296 Approved
0.7565 Intermediate Similarity NPD8379 Approved
0.7544 Intermediate Similarity NPD7516 Approved
0.7374 Intermediate Similarity NPD7524 Approved
0.7353 Intermediate Similarity NPD6399 Phase 3
0.7321 Intermediate Similarity NPD8297 Approved
0.7257 Intermediate Similarity NPD4632 Approved
0.7255 Intermediate Similarity NPD8034 Phase 2
0.7255 Intermediate Similarity NPD8035 Phase 2
0.7248 Intermediate Similarity NPD7128 Approved
0.7248 Intermediate Similarity NPD6675 Approved
0.7248 Intermediate Similarity NPD6402 Approved
0.7248 Intermediate Similarity NPD5739 Approved
0.7245 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD6319 Approved
0.717 Intermediate Similarity NPD4225 Approved
0.7167 Intermediate Similarity NPD7507 Approved
0.7143 Intermediate Similarity NPD6695 Phase 3
0.713 Intermediate Similarity NPD7632 Discontinued
0.7119 Intermediate Similarity NPD7503 Approved
0.7117 Intermediate Similarity NPD7320 Approved
0.7117 Intermediate Similarity NPD6899 Approved
0.7117 Intermediate Similarity NPD6881 Approved
0.7115 Intermediate Similarity NPD7748 Approved
0.7105 Intermediate Similarity NPD8133 Approved
0.7083 Intermediate Similarity NPD7645 Phase 2
0.708 Intermediate Similarity NPD8130 Phase 1
0.7075 Intermediate Similarity NPD7902 Approved
0.7069 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD7115 Discovery
0.7054 Intermediate Similarity NPD6373 Approved
0.7054 Intermediate Similarity NPD6372 Approved
0.7049 Intermediate Similarity NPD7736 Approved
0.7037 Intermediate Similarity NPD5344 Discontinued
0.703 Intermediate Similarity NPD7750 Discontinued
0.7027 Intermediate Similarity NPD5697 Approved
0.7027 Intermediate Similarity NPD5701 Approved
0.7027 Intermediate Similarity NPD6412 Phase 2
0.7021 Intermediate Similarity NPD7339 Approved
0.7021 Intermediate Similarity NPD6942 Approved
0.7 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.6992 Remote Similarity NPD7319 Approved
0.6991 Remote Similarity NPD7102 Approved
0.6991 Remote Similarity NPD6883 Approved
0.6991 Remote Similarity NPD7290 Approved
0.6967 Remote Similarity NPD8293 Discontinued
0.6964 Remote Similarity NPD6686 Approved
0.6964 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6947 Remote Similarity NPD6933 Approved
0.6942 Remote Similarity NPD7492 Approved
0.6937 Remote Similarity NPD6008 Approved
0.693 Remote Similarity NPD6869 Approved
0.693 Remote Similarity NPD6847 Approved
0.693 Remote Similarity NPD6617 Approved
0.693 Remote Similarity NPD6650 Approved
0.693 Remote Similarity NPD6649 Approved
0.6923 Remote Similarity NPD6009 Approved
0.6923 Remote Similarity NPD7515 Phase 2
0.6923 Remote Similarity NPD7637 Suspended
0.6916 Remote Similarity NPD6083 Phase 2
0.6916 Remote Similarity NPD6084 Phase 2
0.6903 Remote Similarity NPD6012 Approved
0.6903 Remote Similarity NPD6013 Approved
0.6903 Remote Similarity NPD6014 Approved
0.69 Remote Similarity NPD4786 Approved
0.6891 Remote Similarity NPD6059 Approved
0.6891 Remote Similarity NPD6054 Approved
0.6885 Remote Similarity NPD6616 Approved
0.687 Remote Similarity NPD6882 Approved
0.686 Remote Similarity NPD8328 Phase 3
0.686 Remote Similarity NPD7604 Phase 2
0.6848 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6837 Remote Similarity NPD7509 Discontinued
0.6837 Remote Similarity NPD6930 Phase 2
0.6837 Remote Similarity NPD6931 Approved
0.6833 Remote Similarity NPD5983 Phase 2
0.6829 Remote Similarity NPD7078 Approved
0.6814 Remote Similarity NPD6011 Approved
0.6804 Remote Similarity NPD6114 Approved
0.6804 Remote Similarity NPD6697 Approved
0.6804 Remote Similarity NPD6118 Approved
0.6804 Remote Similarity NPD6115 Approved
0.6792 Remote Similarity NPD7900 Approved
0.6792 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6783 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6777 Remote Similarity NPD6370 Approved
0.6771 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6759 Remote Similarity NPD4755 Approved
0.6748 Remote Similarity NPD6336 Discontinued
0.6737 Remote Similarity NPD6926 Approved
0.6737 Remote Similarity NPD6924 Approved
0.6735 Remote Similarity NPD6929 Approved
0.6731 Remote Similarity NPD6051 Approved
0.6731 Remote Similarity NPD5328 Approved
0.6724 Remote Similarity NPD6053 Discontinued
0.6701 Remote Similarity NPD6116 Phase 1
0.6701 Remote Similarity NPD6932 Approved
0.67 Remote Similarity NPD3667 Approved
0.6699 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6698 Remote Similarity NPD4202 Approved
0.6696 Remote Similarity NPD4634 Approved
0.6694 Remote Similarity NPD6015 Approved
0.6694 Remote Similarity NPD6016 Approved
0.6667 Remote Similarity NPD7332 Phase 2
0.6639 Remote Similarity NPD5988 Approved
0.6636 Remote Similarity NPD4696 Approved
0.6636 Remote Similarity NPD5285 Approved
0.6636 Remote Similarity NPD6648 Approved
0.6636 Remote Similarity NPD5286 Approved
0.6636 Remote Similarity NPD4700 Approved
0.6604 Remote Similarity NPD6079 Approved
0.6604 Remote Similarity NPD7087 Discontinued
0.6602 Remote Similarity NPD3618 Phase 1
0.66 Remote Similarity NPD6898 Phase 1
0.6598 Remote Similarity NPD6117 Approved
0.6579 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6574 Remote Similarity NPD5695 Phase 3
0.6566 Remote Similarity NPD6683 Phase 2
0.6555 Remote Similarity NPD6274 Approved
0.6552 Remote Similarity NPD6371 Approved
0.6545 Remote Similarity NPD5696 Approved
0.6542 Remote Similarity NPD8171 Discontinued
0.6531 Remote Similarity NPD5776 Phase 2
0.6531 Remote Similarity NPD6925 Approved
0.6529 Remote Similarity NPD7101 Approved
0.6529 Remote Similarity NPD7100 Approved
0.6518 Remote Similarity NPD5225 Approved
0.6518 Remote Similarity NPD5226 Approved
0.6518 Remote Similarity NPD5224 Approved
0.6518 Remote Similarity NPD5211 Phase 2
0.6518 Remote Similarity NPD4633 Approved
0.6509 Remote Similarity NPD7838 Discovery
0.6505 Remote Similarity NPD6893 Approved
0.65 Remote Similarity NPD4748 Discontinued
0.65 Remote Similarity NPD7514 Phase 3
0.6476 Remote Similarity NPD6672 Approved
0.6476 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6476 Remote Similarity NPD5737 Approved
0.6465 Remote Similarity NPD7145 Approved
0.646 Remote Similarity NPD5175 Approved
0.646 Remote Similarity NPD5174 Approved
0.6449 Remote Similarity NPD6411 Approved
0.6446 Remote Similarity NPD6335 Approved
0.6442 Remote Similarity NPD5330 Approved
0.6442 Remote Similarity NPD6409 Approved
0.6442 Remote Similarity NPD7334 Approved
0.6442 Remote Similarity NPD6684 Approved
0.6442 Remote Similarity NPD7146 Approved
0.6442 Remote Similarity NPD7521 Approved
0.6435 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6429 Remote Similarity NPD4159 Approved
0.6429 Remote Similarity NPD5223 Approved
0.6423 Remote Similarity NPD6908 Approved
0.6423 Remote Similarity NPD6909 Approved
0.6422 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6415 Remote Similarity NPD4753 Phase 2
0.6404 Remote Similarity NPD5141 Approved
0.6392 Remote Similarity NPD4785 Approved
0.6392 Remote Similarity NPD4784 Approved
0.6392 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6378 Remote Similarity NPD6033 Approved
0.6364 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6364 Remote Similarity NPD5221 Approved
0.6364 Remote Similarity NPD5222 Approved
0.6364 Remote Similarity NPD6317 Approved
0.6364 Remote Similarity NPD4697 Phase 3
0.6355 Remote Similarity NPD3168 Discontinued
0.6355 Remote Similarity NPD46 Approved
0.6355 Remote Similarity NPD6698 Approved
0.6354 Remote Similarity NPD7150 Approved
0.6354 Remote Similarity NPD7152 Approved
0.6354 Remote Similarity NPD4243 Approved
0.6354 Remote Similarity NPD7151 Approved
0.6348 Remote Similarity NPD4767 Approved
0.6348 Remote Similarity NPD4768 Approved
0.6337 Remote Similarity NPD6928 Phase 2
0.6321 Remote Similarity NPD6903 Approved
0.632 Remote Similarity NPD6067 Discontinued
0.6316 Remote Similarity NPD6922 Approved
0.6316 Remote Similarity NPD6923 Approved
0.6316 Remote Similarity NPD4754 Approved
0.6311 Remote Similarity NPD6313 Approved
0.6311 Remote Similarity NPD6314 Approved
0.6306 Remote Similarity NPD5173 Approved
0.63 Remote Similarity NPD7322 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data